Skip to main navigation Skip to search Skip to main content

First report of an OXA-48-producing multidrug-resistant Proteus mirabilis strain from Gaza, Palestine

  • Liang Chen
  • , Nahed Al Laham
  • , Kalyan D. Chavda
  • , Jose R. Mediavilla
  • , Michael R. Jacobs
  • , Robert A. Bonomo
  • , Barry N. Kreiswirth
  • Public Health Research Institute, New York
  • Al-Azhar University of Gaza
  • Case Western Reserve University
  • Department of Veterans Affairs

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Abstract

We report the first multidrug-resistant Proteus mirabilis strain producing the carbapenemase OXA-48 (Pm-OXA-48) isolated at Al-Shifa hospital in Gaza, Palestine. Draft genome sequencing of Pm-OXA-48 identified 16 antimicrobial resistance genes, encoding resistance to β-lactams, aminoglycosides, fluoroquinolones, phenicols, streptothricin, tetracycline, and trimethoprim-sulfamethoxazole. Complete sequencing of the blaOXA-48-harboring plasmid revealed that it is a 72 kb long IncL/M plasmid, harboring carbapenemase gene blaOXA-48, extended spectrum β-lactamase gene blaCTX-M-14, and aminoglycoside resistance genes strA, strB, and aph(3′)-VIb.

Original languageEnglish
Pages (from-to)4305-4307
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume59
Issue number7
DOIs
StatePublished - 1 Jul 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'First report of an OXA-48-producing multidrug-resistant Proteus mirabilis strain from Gaza, Palestine'. Together they form a unique fingerprint.

Cite this